Although there are not many case reports about liver injury, it is undeniable that it has become a class of AEs that needs to be paid enough attention to liver disorders are often improved with dose reduction or transient discontinuation of EGFR-TKIs, and concomitant use of hepatoprotective agents17. Here, EGFR is linked to liver disorder.